PT  - JOURNAL ARTICLE
AU  - Kobi Cohen
AU  - Amir Leshem
TI  - Suppressing the impact of the COVID-19 pandemic using controlled testing and isolation
AID  - 10.1101/2020.05.03.20089730
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.03.20089730
4099  - http://medrxiv.org/content/early/2020/05/08/2020.05.03.20089730.short
4100  - http://medrxiv.org/content/early/2020/05/08/2020.05.03.20089730.full
AB  - The Corona virus disease 2019 (COVID-19) has significantly affected lives of people around the world. Today, isolation policy is enforced by identifying infected individuals based on symptoms when these appear or by testing people and quarantining those who have been in close contact with infected people. In addition, many countries have imposed complete or partial lock-downs to control the spread of the disease. While this has resulted in some some success in slowing down the spread of the virus, lock-downs as well as widespread quarantine have devastating effects on the economy and social life. Thus, governments are urgently looking for efficient strategies to significantly relax lock-downs, while still controlling the spread of the virus. We argue that this can be done by using active feedback to control testing for infection by actively testing individuals with a high probability of being infected. We develop an active testing strategy to achieve this goal, and demonstrate that it would have tremendous success in controlling the spread of the virus on one million people, using 3,000 tests per day. Our results show up to a 50% reduction in quarantine rate and morbidity rate in typical settings as compared to existing methods.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the U.S.-Israel Binational Science Foundation (BSF) under Grant 2017723, and by the Israel Science Foundation (ISF) under Grant ISF 1644/18Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis paper uses a stochastic agent-based model with synthetic generated data.